SEC Filings

SEC Filings

On April 20, 2020, Melinta Therapeutics announced that it successfully completed its financial restructuring and emerged from Chapter 11. In accordance with the pre-negotiated Chapter 11 plan of reorganization, Melinta is now privately owned by affiliates of Deerfield Management Company, L.P., a healthcare investment firm.

Filing date Description Form Filing Group View

Amendment to a previously filed SC TO-T

SC TO-T/A
Mergers & Acquisitions
View HTML

Tender offer schedule and amendment filed by a third party.

SC TO-T
Mergers & Acquisitions
View HTML

Report of unscheduled material events or corporate event

8-K
Current Reports
View HTML

Post-effective amendment to an S-8 filing

S-8 POS
Registration Statements
View HTML

Post-effective amendment to an S-8 filing

S-8 POS
Registration Statements
View HTML

Post-effective amendment to an S-8 filing

S-8 POS
Registration Statements
View HTML

Post-effective amendment to an S-8 filing

S-8 POS
Registration Statements
View HTML

Post-effective amendment to an S-8 filing

S-8 POS
Registration Statements
View HTML

Post-effective amendment to an S-8 filing

S-8 POS
Registration Statements
View HTML

Post-effective amendment to an S-8 filing

S-8 POS
Registration Statements
View HTML

Data provided by Kaleidoscope.

Melinta Therapeutics, Inc. ©2020 ALL RIGHTS RESERVED | Terms of Use